Shire led to the nullity of the trademark right, Hunterase, against Green Cross

Shire, a company that developed a hunter syndrome treatment ‘Elaprase(idursulfase),’ has succeeded in nullifying a trademark right called ‘Hunterase.’

‘Hunterase(idursulfase)’ developed by Green Cross is a hunter syndrome treatment launched for the 2^nd time in the domestic market in 2013.

After its launch, Hunterase has quickly invaded the Elaprase-monopolized market, recording equivalent sal...